Translating national diabetes policy to transform prevention, treatment and care in your area

09:00 - 09:05

Chair’s opening remarks

09.05 - 09:35

Delivering the diabetes national plan locally: What you need to know following COVID-19

  • Receive an update on how national work is progressing for those living with Type 1 and Type 2, and those at risk of Type 2
  • Understand the impact of the pandemic on diabetes work and how to ensure we do not lose vital learning to improve diabetes prevention, care and treatment
  • Discover the next steps for local implementation, and what they mean for you

Professor Jonathan Valabhji, National Clinical Director for Obesity and Diabetes, NHS England and NHS Improvement 

09:35 - 09:45

Live Q&A

09:45 - 10:00

Short break and session change

10:00 - 10:30

Harnessing technology to improve prevention, care and treatment

  • Hear examples of how technology and digital developments are improving outcomes in diabetes
  • Learn how to ensure that the NHS infrastructure and workforce is prepared for technological developments
  • Discuss how to reduce inequality of access to technology for all those who need it, to support with self-management of diabetes

Anne Cooper, Person with Type 1 Diabetes
Olivia Hind, Partnerships Director, Healthy.io 
Lisa Hollins, Director of Innovation, NHS X
Professor Partha Kar, National Specialty Advisor, Diabetes, NHS England and GIRFT Co-lead, Diabetes, NHS Improvement

10:30 - 10:40

Live Q&A

10:40 - 11:10

Short break and session change

11:10 - 11:40

Adopting a population health approach to improve outcomes

  • Learn how to use data smartly in a population health approach, and how improved interpretation leads to better effectiveness of the approach
  • Understand how a population health management approach can identify who would benefit from additional or different services – and how this came into its own during the pandemic
  • Hear about how an area transformed the care and management of its cohort with a population health approach

Dr Manir Aslam, GP Director and Chair, Strategic Commissioning and Redesign Committee, Sandwell and West Birmingham CCG
Dr Ansu Basu, Consultant Endocrinologist, Sandwell & West Birmingham Hospitals Trust

11:40 - 11:50

Live Q&A

11:50 - 12:05

Short break and session change

12:05 - 12:35

Diabetes and the cardiometabolic challenge

  • Examine the cardiometabolic pathway in the context of COVID-19
  • Manage the cardiovascular risk for those with diabetes
  • Discuss a blueprint for putting together a cardiometabolic pathway

Professor Mark Petrie, Professor of Cardiology, University of Glasgow 
Dr Simon Thackray, Consultant Cardiologist, Scunthorpe General Hospital
Professor Stephen Wheatcroft, Professor of Cardiometabolic Medicine, University of Leeds
(Session in association with Boehringer Ingelheim)

12:35 - 12:50

Live Q&A and Chair’s Closing Remarks

End of live sessions

Download the programme here

Novo Nordisk has provided corporate sponsorship towards the costs of this virtual meeting

Copyright© 2020 Wilmington plc
This programme is a draft, Health Service Journal, part of Wilmington plc, reserves the right to alter the timing and/or speakers at any time.